The Protective Effect of Inhibition of PARP-1 on Inflammation Induced by PM2. 5 in Human Bronchial Epithelial Cell Line

HUANG Qing, ZHANG Jing-jing, ZHANG Zun-zhen

Abstract

To explore whether the inhibition of poly ADP-ribose polymerase-1(PARP-1) could attenuated inflammation induced by fine particulate matter (PM2.5) in human bronchial epithelial cell line. Methods Cell viability was detected by Trypan Blue assay after incubated with PM2.5 for 24 h. PM2.5 doses no more than 600 μg/mL were utilized in the following experiments. In order to observe how PARP-1 would effect the expression of nuclear factor-κB p65 and inducible nitric oxide synthase (iNOS), cells were respectively treated with 600 μg/mL PM2.5, 10 μmol/L 4-amino-1,8-naphthalimide (4-AN), 600 μg/mL PM2.5+10 μmol/L 4-AN or DMSO. Western blot assay was used to estimate the protein expression of PARP-1, p65 in nuclear and iNOS in cytoplasm. Nitric acid enzyme reduction assay was used to determine the production of nitric oxide (NO). Results As the PM2.5 concentration increased, the cell viability decreased, while the expression of PARP-1, p65, iNOS and NO increased significantly (P<0.05). After pretreatment of 4-AN for 24 h, the expression of PARP-1, p65, iNOS and NO almost decreased to the normal level (P>0.05). Conclusion Inflammation triggered by PM2.5 could be attenuated by the inhibition of PAPR-1, which involved the block of transcriptional activity of NF-κB for inflammatory mediator.

 

Keywords: Poly ADP-ribose polymerase-1 (PARP-1), PM2.5, Inflammation NF-κB 

 

Full Text:

PDF


References


FERRERO-MILIANI L. NIELSEN OH. ANDERSON PS. et al. Chronic inflammation; importance of N01)2 and NALP3 in interleukin-1 beta generation. Clin Exp Immunol, 2007.147(2) :227-235.

BARNETT AG. WILLIAMS GM. SCHWARTZ J. et al. Air pollution and child respiratory health a case-crossover study in Australia and new Zealand. Am J Resp Crit Care, 2005.171(11):1272-1278.

RUIZ-ORTEGA M. ESTEBAN V. EGIDO J. The regulation of the inflammatory response through nuclear factor-kappa В pathway by angiotensin | extends the role of the renin angiotensin system in cardiovascular diseases. Trends Cardiovas Med,2007,17(1): 19-25.

BA X, GARG NJ. Signaling mechanism of poly( ADP-ribose) polymerase-1 ( PARP-l ) in inflammatory diseases. Am J Pathol,2011,178(3):946-955.

ZERFAOUI M, ERRAMI Y. NAURA AS, et al. Poly (ADP-ribose) polymerase-1 is a determining factor in crml- mediated nuclear export and retention of p65 NF-kappa В upon TLR4 stimulation. J Immunol, 2010, 185 ( 3 ): 1894- 1902.

VEUGERSJ, HUNTER JE, DURKACZ BW. Ionizing radiation-induced NF-kappa В activation requires PARP-1 function to confer radioresistance. Oncogene, 2009, 28 ( 6 ): 832-842.

RUI W, GUAN L, ZHANG F, et al. PM-induced oxidative stress increases adhesion molecules expression in human endothelial cells through the ERK/AKT/NF-kappaB- dependent pathway. J Appl Toxicol,2016,36( 1) ;48-59.

DING X, WANG M, CHU H, et al. Global gene expression profiling of human bronchial epithelial cells exposed to airborne fine particulate matter collected from Wuhan, China. Toxicol Lett,2014 ,228( 1) ;25-33.

GIBSON BA, KRAUS WL. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat Rev Mol Cell Bio,2012,13(7) :411-424.

HASSA PO, COVIC M, HASAN S, et al. The enzymatic and DNA binding activity of PARP-1 are not required for NF- kappa В coactivator function. J Biol Chem, 2001, 276 ( 49 ) ; 45588-45597.

RICCIARDOLO FLM. STERK PJ, GASTON B, et al. Nitric oxide in health and disease of the respiratory system. Physiol Rev,2004,84(3); 731-765.

JIANG J, MALA VIA N, SURESH V, et al. Nitric oxide gas phase release in human small airway epithelial cells. Resp Res,2009.10(3); 1-8.

FOLKES LK, O'NEILL P. DNA damage induced by nitric oxide during ionizing radiation is enhanced at replication. Nitric Oxide, 2013 ( 34 ); 47-55 [2015-12-04 ]. http://www. sciencedirect. com,/ science/article/pii/Sl 089860313001328.doi: 10. 1016/j. niox. 2013. 04. 005.

CHIARUGI A, MOSKOWITZ MA. Cell biology: PARP-1 a perpetrator of apoptotic cell death? Science,2002,297 (5579);200-201.

MOUCHIROUD L, HOUTKOOPER RH, MOULLAN N, et al. The NAD( + )/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell, 2013,154(2) ;430-441.

PACHER P, VASLIN A, BENKO R, et al. A new, potent poly( AI)P-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging. J Pharmacol Exp Ther,2004,311 (2);485-491.

CURTIN NJ, SZABO C. Therapeutic applications of PARP inhibitors: anticancer therapy and beyond. Mol Aspects Med,2013,34C6; 1217-1256.


Refbacks

  • There are currently no refbacks.